Table of contents
The final phase of the U.S. Drug Supply Chain Security Act (DSCSA) goes into effect later this year on November 27, 2023. Before that deadline, pharmaceutical manufacturers and their supply chain trading partners are required to implement a 100% electronic and interoperable system for the secure exchange of item-level product traceability information.
In this video, Robin Dunchak, Senior Manager of Customer Solutions at Merz Therapeutics, explains why her company chose TraceLink to ensure DSCSA compliance ahead of the upcoming deadline. Watch the video now!
Time Stamps:
- 00:39 - What was the track-and-trace implementation like at Merz Therapeutics and what challenges did you face?
- 02:01 - What results have you achieved so far?
- 02:35 - What advice do you have for other companies facing DSCSA compliance requirements?
- 03:10 - How did the TraceLink "Integrate Once" network model impact your organization?
